AdaptHealth (AHCO) | Stock Overview & Key Data
AdaptHealth Performance Comparison
Stock Range
Today's Range
Low: $8.94
High: $9.25
on October 6, 2025
52 Week Range
Low: $7.11
High: $11.63
on April 21, 2025
on February 27, 2025
All-Time High: $41.58 on February 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.3B
EPS
0.54
P/E Ratio (TTM)
16.83
Forward P/E
10.69
P/B Ratio
0.76
PEG Ratio
-0.73
Div. Yield
N/A
ROE
5.51%
Beta
1.618
Debt to Equity
122.33
Financial Highlights
Profitability
Gross Margin
-9.11%
Operating Margin
7.10%
Profit Margin
2.49%
Returns and Earnings
Return on Assets (TTM)
3.70%
Return on Equity (TTM)
5.51%
EBITDA
$586.8M
Net Income (TTM)
$73.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$24.08
Quarterly Revenue Growth (YoY)
-0.70%
Quarterly Earnings Growth (YoY)
-24.50%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| AdaptHealth AHCO | 1.26B Small-cap | 3.23% | -4.88% | -3.14% | -6.28% | -7.63% | -11.20% | -56.65% | -68.16% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.47% | 1.16% | 0.03% | 7.11% | 17.89% | 15.17% | 32.53% | 21.95% |
| Boston Scientific BSX | 144.20B Large-cap | -0.35% | -10.58% | -6.87% | 5.64% | 8.19% | 11.02% | 141.87% | 151.56% |
| Artivion AORT | 1.98B Small-cap | -3.07% | -6.19% | 34.53% | 76.48% | 45.12% | 57.21% | 291.07% | 112.02% |
| Enovis ENOV | 1.83B Small-cap | 3.58% | -0.45% | -5.33% | -3.82% | -29.44% | -22.28% | -30.50% | -42.68% |
| Novocure NVCR | 1.64B Small-cap | 12.23% | 15.08% | -14.15% | -12.70% | -51.65% | -7.94% | -80.17% | -89.41% |
Ownership & Short Interest
Insider Ownership
8.14%
Institutional Ownership
103.85%
Shares Short
10M
Short Ratio
11.51
Short % of Shares Outstanding
10.03%
Average 10-Day Volume
915K
Average 90-Day Volume
1M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AHCO's 52-week high and low?
- In the last 52 weeks, AdaptHealth reached a high of $11.63 (on February 27, 2025) and a low of $7.11 (on April 21, 2025).
- What is the market cap and P/E ratio for AHCO?
- Curious about AdaptHealth's size and valuation? Its market capitalization stands at 1.26B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.83, and the forward P/E (looking ahead) is 10.69.
- Does AHCO pay dividends? If so, what's the yield?
- As for dividends, AdaptHealth isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are AdaptHealth's main competitors or similar companies to consider before investing?
When looking at AdaptHealth, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 15.17% 32.53% Boston Scientific
BSX144.20B Healthcare Medical Devices 11.02% 141.87% Artivion
AORT1.98B Healthcare Medical Devices 57.21% 291.07% Enovis
ENOV1.83B Healthcare Medical Devices -22.28% -30.50% Novocure
NVCR1.64B Healthcare Medical Devices -7.94% -80.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for AdaptHealth Corp.? (e.g., ROE, Debt/Equity)
- To get a sense of AdaptHealth's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 5.51%, the Debt to Equity ratio from the most recent quarter is 122.33, and its Gross Profit Margin stands at -9.11%.
- What is the recent revenue and earnings growth for AHCO?
- Looking at AdaptHealth's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.70%, and quarterly earnings saw a YoY growth of -24.50%.
- How much of AHCO stock is held by insiders and institutions?
- Wondering who owns AdaptHealth stock? Company insiders (like executives and directors) hold about 8.14% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 103.85%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.